Search research articles
Contact Us
Filters
Showing results (651-660 of 723) with videos related to
Page
of 73
Sort By:
Hormone Research
|
January 1, 1983
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist
F Labrie, A Dupont, A Belanger, et al.
International Journal of Fertility
|
January 1, 1980
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man
F Labrie, L Cusan, C Séguin, et al.
The Journal of Biological Chemistry
|
November 25, 1990
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells
Y Lachance, V Luu-The, C Labrie, et al.
The Journal of Biological Chemistry
|
February 15, 1992
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells
Y Lachance, V Luu-The, C Labrie, et al.
Cancer Metastasis Reviews
|
January 1, 1987
Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience
F Labrie, A Dupont, A Bélanger, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma
F Labrie, A Dupont, M Giguere, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer
F Labrie, A Dupont, L Cusan, et al.
The Prostate
|
February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial
F Labrie, B Candas, A Dupont, et al.
Diabetes Care
|
March 1, 1995
Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue
A Tchernof, J P Després, A Dupont, et al.
Journal of Steroid Biochemistry
|
October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer
F Labrie, A Dupont, L Cusan, et al.
Page
of 73
Search research articles
Search
Showing results (651-660 of 723) with videos related to
Sort By:
Page
of 73
Hormone Research
|
January 1, 1983
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist
F Labrie, A Dupont, A Belanger, et al.
International Journal of Fertility
|
January 1, 1980
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man
F Labrie, L Cusan, C Séguin, et al.
The Journal of Biological Chemistry
|
November 25, 1990
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells
Y Lachance, V Luu-The, C Labrie, et al.
The Journal of Biological Chemistry
|
February 15, 1992
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells
Y Lachance, V Luu-The, C Labrie, et al.
Cancer Metastasis Reviews
|
January 1, 1987
Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience
F Labrie, A Dupont, A Bélanger, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma
F Labrie, A Dupont, M Giguere, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer
F Labrie, A Dupont, L Cusan, et al.
The Prostate
|
February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial
F Labrie, B Candas, A Dupont, et al.
Diabetes Care
|
March 1, 1995
Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue
A Tchernof, J P Després, A Dupont, et al.
Journal of Steroid Biochemistry
|
October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer
F Labrie, A Dupont, L Cusan, et al.
Page
of 73